全文获取类型
收费全文 | 173篇 |
免费 | 22篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 3篇 |
妇产科学 | 1篇 |
基础医学 | 21篇 |
口腔科学 | 7篇 |
临床医学 | 23篇 |
内科学 | 43篇 |
皮肤病学 | 8篇 |
神经病学 | 17篇 |
特种医学 | 4篇 |
外科学 | 19篇 |
预防医学 | 16篇 |
眼科学 | 3篇 |
药学 | 18篇 |
中国医学 | 1篇 |
肿瘤学 | 10篇 |
出版年
2024年 | 1篇 |
2023年 | 4篇 |
2022年 | 5篇 |
2021年 | 13篇 |
2020年 | 9篇 |
2019年 | 7篇 |
2018年 | 12篇 |
2017年 | 5篇 |
2016年 | 7篇 |
2015年 | 10篇 |
2014年 | 16篇 |
2013年 | 10篇 |
2012年 | 13篇 |
2011年 | 26篇 |
2010年 | 7篇 |
2009年 | 9篇 |
2008年 | 10篇 |
2007年 | 3篇 |
2006年 | 8篇 |
2005年 | 4篇 |
2004年 | 10篇 |
2002年 | 3篇 |
2001年 | 1篇 |
2000年 | 1篇 |
1996年 | 1篇 |
1994年 | 1篇 |
排序方式: 共有196条查询结果,搜索用时 31 毫秒
1.
Priyanka Sharma Guojun Wu Deeptha Kumaraswamy Natalie Burchat Hong Ye Yongjia Gong Liping Zhao Yan Y. Lam Harini Sampath 《Nutrients》2021,13(2)
7,8-Dihydroxyflavone (DHF) is a naturally occurring flavonoid that has been reported to protect against a variety of pathologies. Chronic administration of DHF prevents high-fat diet (HFD)-induced obesity in female, but not male, mice. However, the mechanisms underlying this sexual dimorphism have not been elucidated. We have discovered that oral DHF supplementation significantly attenuates fat mass, hepatic lipid accumulation, and adipose tissue inflammation in female mice. In contrast, male mice were not protected from adiposity, and had a paradoxical worsening of hepatic lipid accumulation and adipose tissue inflammation upon DHF supplementation. Consistent with these sexually dimorphic effects on body weight and metabolic health, 7,8-DHF induced early and stable remodeling of the female intestinal microbiome. DHF supplementation significantly increased gut microbial diversity, and suppressed potentially detrimental bacteria, particularly Desulfovibrionaceae, which are pro-inflammatory and positively associated with obesity and inflammation. Changes in the female gut microbiome preceded alterations in body weights, and in silico analyses indicated that these early microbial changes were highly predictive of subsequent weight gain in female mice. While some alterations in the intestinal microbiome were also observed in male DHF-supplemented mice, these changes were distinct from those in females and, importantly, were not predictive of subsequent body weight changes in male animals. The temporality of microbial changes preceding alterations in body weight in female mice suggests a role for the gut microbiome in mediating the sexually dimorphic effects of DHF on body weight. Given the significant clinical interest in this flavonoid across a wide range of pathologies, further elucidation of these sexually dimorphic effects will aid the development of effective clinical therapies. 相似文献
2.
An overview on in situ micronization technique – An emerging novel concept in advanced drug delivery
K.R. Vandana Y. Prasanna Raju V. Harini Chowdary M. Sushma N. Vijay Kumar 《Saudi Pharmaceutical Journal》2014,22(4):283-289
The use of drug powders containing micronized drug particles has been increasing in several pharmaceutical dosage forms to overcome the dissolution and bioavailability problems. Most of the newly developed drugs are poorly water soluble which limits dissolution rate and bioavailability. The dissolution rate can be enhanced by micronization of the drug particles. The properties of the micronized drug substance such as particle size, size distribution, shape, surface properties, and agglomeration behaviour and powder flow are affected by the type of micronization technique used. Mechanical communition, spray drying and supercritical fluid (SCF) technology are the most commonly employed techniques for production of micronized drug particles but the characteristics of the resulting drug product cannot be controlled using these techniques. Hence, a newer technique called in situ micronization is developed in order to overcome the limitations associated with the other techniques. This review summarizes the existing knowledge on in situ micronization techniques. The properties of the resulting drug substance obtained by in situ micronization were also compared. 相似文献
3.
Jonathan G. Amatruda MD Ronit Katz DPhil Carmen A. Peralta MD MAS Michelle M. Estrella MD MHS Harini Sarathy MBBS MHS Linda F. Fried MD MPH Anne B. Newman MD MPH Chirag R. Parikh MBBS PhD Joachim H. Ix MD MAS Mark J. Sarnak MD MS Michael G. Shlipak MD MPH for the Health ABC Study 《Journal of the American Geriatrics Society》2021,69(3):726-734
4.
William R. Morgenlander Stephanie N. Henson Daniel R. Monaco Athena Chen Kirsten Littlefield Evan M. Bloch Eric Fujimura Ingo Ruczinski Andrew R. Crowley Harini Natarajan Savannah E. Butler Joshua A. Weiner Mamie Z. Li Tania S. Bonny Sarah E. Benner Ashwin Balagopal David Sullivan Shmuel Shoham Thomas C. Quinn Susan H. Eshleman Arturo Casadevall Andrew D. Redd Oliver Laeyendecker Margaret E. Ackerman Andrew Pekosz Stephen J. Elledge Matthew Robinson Aaron A.R. Tobian H. Benjamin Larman 《The Journal of clinical investigation》2021,131(7)
SARS-CoV-2 (CoV2) antibody therapies, including COVID-19 convalescent plasma (CCP), monoclonal antibodies, and hyperimmune globulin, are among the leading treatments for individuals with early COVID-19 infection. The functionality of convalescent plasma varies greatly, but the association of antibody epitope specificities with plasma functionality remains uncharacterized. We assessed antibody functionality and reactivities to peptides across the CoV2 and the 4 endemic human coronavirus (HCoV) genomes in 126 CCP donations. We found strong correlation between plasma functionality and polyclonal antibody targeting of CoV2 spike protein peptides. Antibody reactivity to many HCoV spike peptides also displayed strong correlation with plasma functionality, including pan-coronavirus cross-reactive epitopes located in a conserved region of the fusion peptide. After accounting for antibody cross-reactivity, we identified an association between greater alphacoronavirus NL63 antibody responses and development of highly neutralizing antibodies against CoV2. We also found that plasma preferentially reactive to the CoV2 spike receptor binding domain (RBD), versus the betacoronavirus HKU1 RBD, had higher neutralizing titer. Finally, we developed a 2-peptide serosignature that identifies plasma donations with high anti-spike titer, but that suffer from low neutralizing activity. These results suggest that analysis of coronavirus antibody fine specificities may be useful for selecting desired therapeutics and understanding the complex immune responses elicited by CoV2 infection. 相似文献
5.
Breast cancer subtype intertumor heterogeneity: MRI‐based features predict results of a genomic assay 下载免费PDF全文
6.
7.
Sanja Dragovic Harini Venkataraman Selina Begheijn Nico P.E. VermeulenJan N.M. Commandeur 《Toxicology letters》2014
Recent association studies suggest that genetically determined deficiencies in GSTs might be a risk factor for idiosyncratic adverse drug reactions resulting from the formation of reactive drug metabolites. hGSTP1-1 is polymorphic in the human population with a number of single nucleotide polymorphisms that yield an amino acid change in the encoded protein. Three allelic variants of hGSTP1-1 containing an Ile105Val or Ala114Val substitution, or a combination of both, have been the most widely studied and showed different activity when compared to wild-type hGSTP1-1*A (Ile105/Ala114). In the present study, we studied the ability of these allelic variants to catalyze the GSH conjugation of reactive metabolites of acetaminophen, clozapine, and diclofenac formed by bioactivation in in vitro incubations by human liver microsomes and drug metabolizing P450 BM3 mutants. The results show that effects of the change of amino acid at residue 105 and 114 on conjugation reactions were substrate dependent. A single substitution at residue 105 affects the ability to catalyze GSH conjugation, while when both residue 105 and 114 were substituted the effect was additionally enhanced. Single mutation at position 114 did not show a significant effect. The different hGSTP1-1 mutants showed slightly altered regioselectivities in formation of individual GSH conjugates of clozapine which suggests that the binding orientation of the reactive nitrenium ion of clozapine is affected by the mutations. For diclofenac, a significant decrease in activity in GSH-conjugation of diclofenac 1′,4′-quinone imine was observed for variants hGSTP1-1*B (Val105/Ala114) and hGSTP1-1*C (Val105/Val114). However, since the differences in total GSH conjugation activity catalyzed by these allelic variants were not higher than 30%, differences in inactivation of reactive intermediates by hGSTP1-1 are not likely to be a major factor in determining interindividual difference in susceptibility to adverse drug reactions induced by the drugs studied. 相似文献
8.
9.
10.